US Foods Reports Third Quarter Fiscal Year 2022 Earnings
US Foods Holding Corp. (NYSE: USFD) reported impressive third-quarter fiscal 2022 results, with net income rising to $100 million, a $45 million increase year-over-year. Adjusted EBITDA increased by 20.6% to $351 million. The company achieved net sales of $8.9 billion, a 13% increase, driven by food cost inflation. Gross profit also rose by 17.6% to $1.5 billion. To enhance shareholder value, the Board announced a $500 million share repurchase program. The updated fiscal guidance anticipates adjusted EBITDA between $1.28-$1.30 billion and adjusted diluted EPS of $2.10-$2.20.
- Adjusted EBITDA increased by 20.6% to $351 million.
- Net sales of $8.9 billion, up 13% year-over-year.
- Gross profit grew by 17.6%, reaching $1.5 billion.
- Board approved a $500 million share repurchase program.
- Total operating expenses increased by 12.7% to $1.2 billion, influenced by higher labor costs.
- Independent restaurant case volume increase of only 2.9%, indicating slower growth in this segment.
Announces
Third Quarter Fiscal 2022 Highlights
-
Net income available to common shareholders improved to
$100 million -
Adjusted EBITDA increased
20.6% to$351 million -
Diluted EPS was
; Adjusted Diluted EPS was$0.43 $0.60 -
Net sales increased
13.0% to$8.9 billion -
Total case volume increased
0.7% ; independent restaurant case volume increased2.9% -
Gross profit increased
17.6% to$1.5 billion
Nine Month Fiscal 2022 Highlights
-
Net income available to common shareholders was
$145 million -
Adjusted EBITDA increased
20.8% to$960 million -
Diluted EPS was
; Adjusted Diluted EPS was$0.64 $1.59 -
Net sales increased
16.9% to$25.5 billion -
Total case volume increased
1.3% ; independent restaurant case volume increased3.8% -
Gross profit increased
18.3% to$4.0 billion
CEO Perspective
“US Foods delivered strong results in the third quarter as we continue to execute on the three pillars of our long-range plan, which we introduced earlier this year,” said
Third Quarter Fiscal 2022 Results
Net income available to common shareholders was
Net sales were
Gross profit was
Total operating expenses of
Nine Month Fiscal 2022 Results
Net income available to common shareholders was
Net sales were
Gross profit was
Total operating expenses of
Cash Flow and Debt
Cash flow provided by operating activities for the first nine months of fiscal 2022 was
During the third quarter of fiscal 2022, the Company used cash-on-hand to make a
Net Debt at the end of the third quarter of fiscal 2022 was
Share Repurchase Program
The Company's Board of Directors has approved a share repurchase program under which the Company is authorized to repurchase up to
Outlook for Fiscal Year 20221
The Company is updating its 2022 guidance to:
-
Adjusted EBITDA of
$1.28 -$1.30 billion -
Adjusted Diluted EPS of
$2.10 -$2.20 -
Interest expense of
$250 -$255 million -
Cash capital expenditures of
with fleet capital leases to be an additional$270 -$280 million ~ $125 million - Net Debt to Adjusted EBITDA leverage of approximately 3.5x by end of fiscal year 2022
_______________________________
1 The Company is not providing a reconciliation of certain forward-looking non-GAAP financial measures, including Adjusted EBITDA and Adjusted Diluted EPS, because the Company is unable to predict with reasonable certainty the financial impact of certain significant items, including restructuring costs and asset impairment charges, share-based compensation expenses, non-cash impacts of LIFO reserve adjustments, losses on extinguishments of debt, business transformation costs, other gains and losses, business acquisition and integration related costs and diluted earnings per share. These items are uncertain, depend on various factors, and could have a material impact on GAAP reported results for the guidance periods. For the same reasons, the Company is unable to address the significance of the unavailable information, which could be material to future results.
Conference Call and Webcast Information
About
With a promise to help its customers Make It,
Forward-Looking Statements
Statements in this press release which are not historical in nature, including those under the heading “Share Repurchase Program” and “Outlook for Fiscal Year 2022” and about the anticipated size and timing of our share repurchases and the anticipated impact thereof on our financial performance and liquidity are “forward-looking statements” within the meaning of the federal securities laws. These statements often include words such as “believe,” “expect,” “project,” “anticipate,” “intend,” “plan,” “outlook,” “estimate,” “target,” “seek,” “will,” “may,” “would,” “should,” “could,” “forecast,” “mission,” “strive,” “more,” “goal,” or similar expressions (although not all forward-looking statements may contain such words) and are based upon various assumptions and our experience in the industry, as well as historical trends, current conditions, and expected future developments. However, you should understand that these statements are not guarantees of performance or results and there are a number of risks, uncertainties and other important factors that could cause our actual results to differ materially from those expressed in the forward-looking statements, including, among others: economic factors affecting consumer confidence and discretionary spending and reducing the consumption of food prepared away from home; cost inflation/deflation and volatile commodity costs; increases in food and fuel costs; competition; reliance on third party suppliers and interruption of product supply or increases in product costs; changes in our relationships with customers and group purchasing organizations; our ability to increase or maintain the highest margin portions of our business; achievement of expected benefits from cost savings initiatives; changes in consumer eating habits; cost and pricing structures; the extent and duration of the negative impact of the COVID-19 pandemic on us; environmental, health and safety and other governmental regulation, including actions taken by national, state and local governments to contain the COVID-19 pandemic, such as travel restrictions or bans, social distancing requirements, and required closures of non-essential businesses; impairment charges for goodwill, indefinite-lived intangible assets or other long-lived assets; product recalls and product liability claims; our reputation in the industry; indebtedness and restrictions under agreements governing our indebtedness; interest rate increases; the replacement of London Interbank Offered Rate with an alternative reference rate; labor relations and increased labor costs and continued access to qualified and diverse labor; risks associated with intellectual property, including potential infringement; disruption of existing technologies and implementation of new technologies; cybersecurity incidents and other technology disruptions; effective integration of acquired businesses; changes in tax laws and regulations and resolution of tax disputes; costs and risks associated with current and changing government laws and regulations; adverse judgments or settlements resulting from litigation; extreme weather conditions, natural disasters and other catastrophic events, including pandemics and the rapid spread of contagious illnesses; and management of retirement benefits and pension obligations.
For a detailed discussion of these risks, uncertainties and other factors that could cause our results to differ materially from those anticipated or expressed in any forward-looking statements, see the section entitled “Risk Factors” in our Annual Report on Form 10-K for the fiscal year ended
Non-GAAP Financial Measures
We report our financial results in accordance with
We use Adjusted Gross profit and Adjusted Operating expenses as supplemental measures to GAAP measures to focus on period-over-period changes in our business and believe this information is helpful to investors. Adjusted Gross profit is Gross profit adjusted to remove the impact of the LIFO inventory reserve adjustments. Adjusted Operating expenses are Operating expenses adjusted to exclude amounts that we do not consider part of our core operating results when assessing our performance.
We believe EBITDA, Adjusted EBITDA and Adjusted EBITDA margin provide meaningful supplemental information about our operating performance because they exclude amounts that we do not consider part of our core operating results when assessing our performance. EBITDA is Net income, plus Interest expense-net, Income tax provision, and Depreciation and amortization. Adjusted EBITDA is EBITDA adjusted for (1) Restructuring costs and asset impairment charges; (2) Share-based compensation expense; (3) the non-cash impact of LIFO reserve adjustments; (4) loss on extinguishment of debt; (5) Business transformation costs; and (6) other gains, losses or costs as specified in the agreements governing our indebtedness. Adjusted EBITDA margin is Adjusted EBITDA divided by total net sales.
We use Net Debt and Net Leverage Ratio as supplemental measures to GAAP measures to review the liquidity of our operations. Net Debt is defined as total debt net of total Cash, cash equivalents and restricted cash remaining on the balance sheet as of the end of the most recent fiscal quarter. Net Leverage Ratio represents Net Debt divided by Trailing Twelve Months Adjusted EBITDA. We believe that Net Debt and Net Leverage Ratio are useful financial metrics to assess our ability to pursue business opportunities and investments. Net Debt is not a measure of our liquidity under GAAP and should not be considered as an alternative to Cash Flows Provided by Operations or Cash Flows Used in Financing Activities.
We believe that Adjusted Net income is a useful measure of operating performance for both management and investors because it excludes items that are not reflective of our core operating performance and provides an additional view of our operating performance including depreciation, interest expense, and Income taxes on a consistent basis from period to period. Adjusted Net income is Net income excluding such items as restructuring costs and asset impairment charges, Share-based compensation expense, the non-cash impacts of LIFO reserve adjustments, loss on extinguishment of debt, Business transformation costs and other items, and adjusted for the tax effect of the exclusions and discrete tax items. We believe that Adjusted Net income may be used by investors, analysts, and other interested parties to facilitate period-over-period comparisons and provides additional clarity as to how factors and trends impact our operating performance.
We use Adjusted Diluted Earnings per Share, which is calculated by adjusting the most directly comparable GAAP financial measure, Diluted Earnings per Share, by excluding the same items excluded in our calculation of Adjusted EBITDA to the extent that each such item was included in the applicable GAAP financial measure. We believe the presentation of Adjusted Diluted Earnings per Share is useful to investors because the measurement excludes amounts that we do not consider part of our core operating results when assessing our performance. We also believe that the presentation of Adjusted EBITDA, Adjusted EBITDA margin and Adjusted Diluted Earnings per Share is useful to investors because these metrics may be used by securities analysts, investors and other interested parties in their evaluation of the operating performance of companies in our industry.
Management uses these non-GAAP financial measures (a) to evaluate our historical and prospective financial performance as well as our performance relative to our competitors as they assist in highlighting trends, (b) to set internal sales targets and spending budgets, (c) to measure operational profitability and the accuracy of forecasting, (d) to assess financial discipline over operational expenditures, and (e) as an important factor in determining variable compensation for management and employees. EBITDA and Adjusted EBITDA are also used in connection with certain covenants and restricted activities under the agreements governing our indebtedness. We also believe these and similar non-GAAP financial measures are frequently used by securities analysts, investors, and other interested parties to evaluate companies in our industry.
We caution readers that our definitions of Adjusted Gross profit, Adjusted Operating expenses, EBITDA, Adjusted EBITDA, Adjusted EBITDA margin, Adjusted Net income, Adjusted Diluted EPS, Net Debt and Net Leverage Ratio may not be calculated in the same manner as similar measures used by other companies. Definitions and reconciliations of the non-GAAP financial measures to their most comparable GAAP financial measures are included in the schedules attached to this press release.
Source:
Consolidated Balance Sheets (Unaudited) |
||||||||
($ in millions) |
|
|
|
|
||||
|
|
|
|
|
||||
ASSETS |
|
|
|
|
||||
Current assets: |
|
|
|
|
||||
Cash and cash equivalents |
|
$ |
366 |
|
|
$ |
148 |
|
Accounts receivable, less allowances of |
|
|
1,853 |
|
|
|
1,469 |
|
Vendor receivables, less allowances of |
|
|
193 |
|
|
|
145 |
|
Inventories—net |
|
|
1,761 |
|
|
|
1,686 |
|
Prepaid expenses |
|
|
106 |
|
|
|
120 |
|
Assets held for sale |
|
|
8 |
|
|
|
8 |
|
Other current assets |
|
|
11 |
|
|
|
18 |
|
Total current assets |
|
|
4,298 |
|
|
|
3,594 |
|
Property and equipment—net |
|
|
2,075 |
|
|
|
2,033 |
|
|
|
|
5,625 |
|
|
|
5,625 |
|
Other intangibles—net |
|
|
797 |
|
|
|
830 |
|
Deferred tax assets |
|
|
— |
|
|
|
8 |
|
Other assets |
|
|
447 |
|
|
|
431 |
|
Total assets |
|
$ |
13,242 |
|
|
$ |
12,521 |
|
|
|
|
|
|
||||
LIABILITIES, MEZZANINE EQUITY AND SHAREHOLDERS’ EQUITY |
|
|
|
|
||||
Current liabilities: |
|
|
|
|
||||
Cash overdraft liability |
|
$ |
219 |
|
|
$ |
183 |
|
Accounts payable |
|
|
2,180 |
|
|
|
1,662 |
|
Accrued expenses and other current liabilities |
|
|
671 |
|
|
|
610 |
|
Current portion of long-term debt |
|
|
100 |
|
|
|
95 |
|
Total current liabilities |
|
|
3,170 |
|
|
|
2,550 |
|
Long-term debt |
|
|
4,837 |
|
|
|
4,916 |
|
Deferred tax liabilities |
|
|
298 |
|
|
|
307 |
|
Other long-term liabilities |
|
|
476 |
|
|
|
479 |
|
Total liabilities |
|
|
8,781 |
|
|
|
8,252 |
|
Mezzanine equity: |
|
|
|
|
||||
Series A convertible preferred stock |
|
|
534 |
|
|
|
534 |
|
Shareholders’ equity: |
|
|
|
|
||||
Common stock |
|
|
2 |
|
|
|
2 |
|
Additional paid-in capital |
|
|
3,017 |
|
|
|
2,970 |
|
Retained earnings |
|
|
927 |
|
|
|
782 |
|
Accumulated other comprehensive loss |
|
|
(19 |
) |
|
|
(19 |
) |
Total shareholders’ equity |
|
|
3,927 |
|
|
|
3,735 |
|
Total liabilities, mezzanine equity and shareholders’ equity |
|
$ |
13,242 |
|
|
$ |
12,521 |
|
Consolidated Statements of Operations (Unaudited) |
|||||||||||
|
13 Weeks Ended |
|
39 Weeks Ended |
||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
|
|
||||
Net sales |
$ |
8,917 |
|
$ |
7,890 |
|
$ |
25,542 |
|
$ |
21,848 |
Cost of goods sold |
|
7,457 |
|
|
6,649 |
|
|
21,504 |
|
|
18,435 |
Gross profit |
|
1,460 |
|
|
1,241 |
|
|
4,038 |
|
|
3,413 |
Operating expenses: |
|
|
|
|
|
|
|
||||
Distribution, selling and administrative costs |
|
1,246 |
|
|
1,099 |
|
|
3,640 |
|
|
3,115 |
Restructuring costs and asset impairment charges |
|
— |
|
|
7 |
|
|
— |
|
|
11 |
Total operating expenses |
|
1,246 |
|
|
1,106 |
|
|
3,640 |
|
|
3,126 |
Operating income |
|
214 |
|
|
135 |
|
|
398 |
|
|
287 |
Other income—net |
|
(5) |
|
|
(6) |
|
|
(16) |
|
|
(19) |
Interest expense—net |
|
65 |
|
|
50 |
|
|
180 |
|
|
158 |
Loss on extinguishment of debt |
|
— |
|
|
— |
|
|
— |
|
|
23 |
Income before income taxes |
|
154 |
|
|
91 |
|
|
234 |
|
|
125 |
Income tax provision |
|
45 |
|
|
27 |
|
|
62 |
|
|
30 |
Net income |
$ |
109 |
|
$ |
64 |
|
$ |
172 |
|
$ |
95 |
|
|
|
|
|
|
|
|
||||
Net income |
$ |
109 |
|
$ |
64 |
|
$ |
172 |
|
$ |
95 |
Series A convertible preferred stock dividends |
|
(9) |
|
|
(9) |
|
|
(27) |
|
|
(33) |
Net income available to common shareholders |
$ |
100 |
|
$ |
55 |
|
$ |
145 |
|
$ |
62 |
|
|
|
|
|
|
|
|
||||
Net income per share |
|
|
|
|
|
|
|
||||
Basic |
$ |
0.44 |
|
$ |
0.25 |
|
$ |
0.65 |
|
$ |
0.28 |
Diluted |
$ |
0.43 |
|
$ |
0.24 |
|
$ |
0.64 |
|
$ |
0.28 |
|
|
|
|
|
|
|
|
||||
Weighted-average common shares outstanding |
|
|
|
|
|
|
|
||||
Basic |
|
224,584,298 |
|
|
222,313,747 |
|
|
223,840,992 |
|
|
221,624,799 |
Diluted |
|
251,174,198 |
|
|
225,240,185 |
|
|
226,300,639 |
|
|
225,072,474 |
|
|
|
|
|
|
|
|
Consolidated Statements of Cash Flows (Unaudited) |
||||||||
|
|
39 Weeks Ended |
||||||
($ in millions) |
|
|
|
|
||||
Cash flows from operating activities: |
|
|
|
|
||||
Net income |
|
$ |
172 |
|
|
$ |
95 |
|
Adjustments to reconcile net income to net cash provided by operating activities: |
|
|
|
|
||||
Depreciation and amortization |
|
|
273 |
|
|
|
286 |
|
Gain on disposal of property and equipment—net |
|
|
(2 |
) |
|
|
— |
|
Intangible asset impairment charges |
|
|
— |
|
|
|
7 |
|
Loss on extinguishment of debt |
|
|
— |
|
|
|
23 |
|
Amortization of deferred financing costs |
|
|
10 |
|
|
|
10 |
|
Deferred tax provision |
|
|
(1 |
) |
|
|
19 |
|
Share-based compensation expense |
|
|
34 |
|
|
|
36 |
|
Provision (benefit) for doubtful accounts |
|
|
3 |
|
|
|
(18 |
) |
Changes in operating assets and liabilities: |
|
|
|
|
||||
Increase in receivables |
|
|
(435 |
) |
|
|
(530 |
) |
Increase in inventories—net |
|
|
(74 |
) |
|
|
(292 |
) |
Decrease in prepaid expenses and other assets |
|
|
2 |
|
|
|
9 |
|
Increase in accounts payable and cash overdraft liability |
|
|
574 |
|
|
|
780 |
|
Increase in accrued expenses and other liabilities |
|
|
57 |
|
|
|
95 |
|
Net cash provided by operating activities |
|
|
613 |
|
|
|
520 |
|
Cash flows from investing activities: |
|
|
|
|
||||
Proceeds from sales of divested assets |
|
|
— |
|
|
|
5 |
|
Proceeds from sales of property and equipment |
|
|
4 |
|
|
|
2 |
|
Purchases of property and equipment |
|
|
(201 |
) |
|
|
(173 |
) |
Net cash used in investing activities |
|
|
(197 |
) |
|
|
(166 |
) |
Cash flows from financing activities: |
|
|
|
|
||||
Proceeds from debt borrowings |
|
|
1,031 |
|
|
|
900 |
|
Principal payments on debt and financing leases |
|
|
(1,215 |
) |
|
|
(1,291 |
) |
Dividends paid on Series A convertible preferred stock |
|
|
(27 |
) |
|
|
(18 |
) |
Debt financing costs and fees |
|
|
— |
|
|
|
(18 |
) |
Proceeds from employee stock purchase plan |
|
|
17 |
|
|
|
16 |
|
Proceeds from exercise of stock options |
|
|
12 |
|
|
|
13 |
|
Tax withholding payments for net share-settled equity awards |
|
|
(16 |
) |
|
|
(13 |
) |
Net cash used in financing activities |
|
|
(198 |
) |
|
|
(411 |
) |
Net increase (decrease) in cash, and cash equivalents and restricted cash |
|
|
218 |
|
|
|
(57 |
) |
Cash, cash equivalents and restricted cash—beginning of period |
|
|
148 |
|
|
|
829 |
|
Cash, cash equivalents and restricted cash—end of period |
|
$ |
366 |
|
|
$ |
772 |
|
Supplemental disclosures of cash flow information: |
|
|
|
|
||||
Interest paid—net of amounts capitalized |
|
$ |
162 |
|
|
$ |
134 |
|
Income taxes paid—net |
|
|
45 |
|
|
|
— |
|
Property and equipment purchases included in accounts payable |
|
|
25 |
|
|
|
32 |
|
Property and equipment transferred to assets held for sale |
|
|
— |
|
|
|
11 |
|
Leased assets obtained in exchange for financing lease liabilities |
|
|
98 |
|
|
|
24 |
|
Leased assets obtained in exchange for operating lease liabilities |
|
|
35 |
|
|
|
24 |
|
Cashless exercise of stock options |
|
|
1 |
|
|
|
1 |
|
Paid-in-kind Series A convertible preferred stock dividends |
|
|
— |
|
|
|
15 |
|
Non-GAAP Reconciliation (Unaudited) |
|||||||||||||||
|
|
13 Weeks Ended |
|
|
|
|
|||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
Change |
|
% |
|||||||
Net income available to common shareholders |
|
$ |
100 |
|
|
$ |
55 |
|
|
$ |
45 |
|
|
81.8 |
% |
Series A Preferred Stock Dividends |
|
|
(9 |
) |
|
|
(9 |
) |
|
|
— |
|
|
— |
% |
Net income (GAAP) |
|
|
109 |
|
|
|
64 |
|
|
|
45 |
|
|
70.3 |
% |
Interest expense—net |
|
|
65 |
|
|
|
50 |
|
|
|
15 |
|
|
30.0 |
% |
Income tax provision |
|
|
45 |
|
|
|
27 |
|
|
|
18 |
|
|
66.7 |
% |
Depreciation expense |
|
|
81 |
|
|
|
79 |
|
|
|
2 |
|
|
2.5 |
% |
Amortization expense |
|
|
11 |
|
|
|
12 |
|
|
|
(1 |
) |
|
(8.3 |
)% |
EBITDA (Non-GAAP) |
|
|
311 |
|
|
|
232 |
|
|
|
79 |
|
|
34.1 |
% |
Adjustments: |
|
|
|
|
|
|
|
|
|||||||
Restructuring costs and asset impairment charges (1) |
|
|
— |
|
|
|
7 |
|
|
|
(7 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
13 |
|
|
|
13 |
|
|
|
— |
|
|
— |
% |
LIFO reserve adjustment (3) |
|
|
6 |
|
|
|
32 |
|
|
|
(26 |
) |
|
(81.3 |
)% |
Business transformation costs (4) |
|
|
12 |
|
|
|
3 |
|
|
|
9 |
|
|
NM |
|
Business acquisition and integration related costs and other (5) |
|
|
9 |
|
|
|
4 |
|
|
|
5 |
|
|
125.0 |
% |
Adjusted EBITDA (Non-GAAP) |
|
|
351 |
|
|
|
291 |
|
|
|
60 |
|
|
20.6 |
% |
Depreciation expense |
|
|
(81 |
) |
|
|
(79 |
) |
|
|
(2 |
) |
|
2.5 |
% |
Interest expense—net |
|
|
(65 |
) |
|
|
(50 |
) |
|
|
(15 |
) |
|
30.0 |
% |
Income tax provision, as adjusted (7) |
|
|
(54 |
) |
|
|
(43 |
) |
|
|
(11 |
) |
|
25.6 |
% |
Adjusted Net Income (Non-GAAP) |
|
$ |
151 |
|
|
$ |
119 |
|
|
$ |
32 |
|
|
26.9 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS (GAAP) |
|
$ |
0.43 |
|
|
$ |
0.24 |
|
|
$ |
0.19 |
|
|
79.2 |
% |
Restructuring and asset impairment costs (1) |
|
|
— |
|
|
|
0.03 |
|
|
|
(0.03 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
0.05 |
|
|
|
0.05 |
|
|
|
— |
|
|
— |
% |
LIFO reserve adjustment (3) |
|
|
0.02 |
|
|
|
0.13 |
|
|
|
(0.11 |
) |
|
(84.6 |
)% |
Business transformation costs (4) |
|
|
0.05 |
|
|
|
0.01 |
|
|
|
0.04 |
|
|
NM |
|
Business acquisition and integration related costs and other (5) |
|
|
0.04 |
|
|
|
0.02 |
|
|
|
0.02 |
|
|
100.0 |
% |
Income tax provision, as adjusted (6) |
|
|
0.01 |
|
|
|
— |
|
|
|
0.01 |
|
|
NM |
|
Adjusted Diluted EPS (Non-GAAP) (7) |
|
$ |
0.60 |
|
|
$ |
0.48 |
|
|
$ |
0.12 |
|
|
25.0 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Weighted-average diluted shares outstanding (Non-GAAP) (8) |
|
|
251,174,198 |
|
|
|
249,997,426 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
Gross profit (GAAP) |
|
$ |
1,460 |
|
|
$ |
1,241 |
|
|
$ |
219 |
|
|
17.6 |
% |
LIFO reserve change (3) |
|
|
6 |
|
|
|
32 |
|
|
|
(26 |
) |
|
(81.3 |
)% |
Adjusted Gross profit (Non-GAAP) |
|
$ |
1,466 |
|
|
$ |
1,273 |
|
|
$ |
193 |
|
|
15.2 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses (GAAP) |
|
$ |
1,246 |
|
|
$ |
1,106 |
|
|
$ |
140 |
|
|
12.7 |
% |
Depreciation expense |
|
|
(81 |
) |
|
|
(79 |
) |
|
|
(2 |
) |
|
2.5 |
% |
Amortization expense |
|
|
(11 |
) |
|
|
(12 |
) |
|
|
1 |
|
|
(8.3 |
)% |
Restructuring costs and asset impairment charges (1) |
|
|
— |
|
|
|
(7 |
) |
|
|
7 |
|
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
(13 |
) |
|
|
(13 |
) |
|
|
— |
|
|
— |
% |
Business transformation costs (4) |
|
|
(12 |
) |
|
|
(3 |
) |
|
|
(9 |
) |
|
NM |
|
Business acquisition and integration related costs and other (5) |
|
|
(9 |
) |
|
|
(4 |
) |
|
|
(5 |
) |
|
125.0 |
% |
Adjusted Operating expenses (Non-GAAP) |
|
$ |
1,120 |
|
|
$ |
988 |
|
|
$ |
132 |
|
|
13.4 |
% |
NM - Not Meaningful | ||
(1) |
Consists primarily of non-CEO severance and related costs, organizational realignment costs and asset impairment charges. |
|
(2) |
Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan. |
|
(3) |
Represents the impact of LIFO reserve adjustments. |
|
(4) |
Consists primarily of costs related to significant process and systems redesign across multiple functions. |
|
(5) |
Includes: (i) aggregate acquisition and integration related costs of |
|
(6) |
Represents our income tax provision adjusted for the tax effect of pre-tax items excluded from Adjusted net income and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted net income is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances. |
|
(7) |
Adjusted Diluted EPS is calculated as Adjusted net income divided by weighted average diluted shares outstanding (Non-GAAP). |
|
(8) |
For purposes of the Adjusted Diluted EPS calculation (Non-GAAP), when the Company has net income (GAAP), weighted average diluted shares outstanding (Non-GAAP) is used and assumes conversion of the Series A convertible preferred stock, and, when the Company has net loss (GAAP) and assumed conversion of the Series A convertible preferred stock would be antidilutive, weighted-average diluted shares outstanding (GAAP) is used. |
Non-GAAP Reconciliation (Unaudited) |
|||||||||||||||
|
|
39 Weeks Ended |
|
|
|
|
|||||||||
($ in millions, except share and per share data) |
|
|
|
|
|
Change |
|
% |
|||||||
Net income available to common shareholders |
|
$ |
145 |
|
|
$ |
62 |
|
|
$ |
83 |
|
|
133.9 |
% |
Series A convertible preferred stock dividends |
|
|
(27 |
) |
|
|
(33 |
) |
|
|
6 |
|
|
(18.2 |
)% |
Net income (GAAP) |
|
|
172 |
|
|
|
95 |
|
|
|
77 |
|
|
81.1 |
% |
Interest expense—net |
|
|
180 |
|
|
|
158 |
|
|
|
22 |
|
|
13.9 |
% |
Income tax provision |
|
|
62 |
|
|
|
30 |
|
|
|
32 |
|
|
106.7 |
% |
Depreciation expense |
|
|
240 |
|
|
|
242 |
|
|
|
(2 |
) |
|
(0.8 |
)% |
Amortization expense |
|
|
33 |
|
|
|
44 |
|
|
|
(11 |
) |
|
(25.0 |
)% |
EBITDA (Non-GAAP) |
|
|
687 |
|
|
|
569 |
|
|
|
118 |
|
|
20.7 |
% |
Adjustments: |
|
|
|
|
|
|
|
|
|||||||
Restructuring and asset impairment costs(1) |
|
|
— |
|
|
|
11 |
|
|
|
(11 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
34 |
|
|
|
36 |
|
|
|
(2 |
) |
|
(5.6 |
)% |
LIFO reserve change (3) |
|
|
143 |
|
|
|
150 |
|
|
|
(7 |
) |
|
(4.7 |
)% |
Loss on extinguishment of debt (4) |
|
|
— |
|
|
|
23 |
|
|
|
(23 |
) |
|
(100.0 |
)% |
Business transformation costs (5) |
|
|
41 |
|
|
|
17 |
|
|
|
24 |
|
|
141.2 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
(15 |
) |
|
|
15 |
|
|
(100.0 |
)% |
COVID-19 other related expenses (7) |
|
|
2 |
|
|
|
1 |
|
|
|
1 |
|
|
100.0 |
% |
Business acquisition and integration related costs and other (8) |
|
|
53 |
|
|
|
3 |
|
|
|
50 |
|
|
NM |
|
Adjusted EBITDA (Non-GAAP) |
|
|
960 |
|
|
|
795 |
|
|
|
165 |
|
|
20.8 |
% |
Depreciation expense |
|
|
(240 |
) |
|
|
(242 |
) |
|
|
2 |
|
|
(0.8 |
)% |
Interest expense—net |
|
|
(180 |
) |
|
|
(158 |
) |
|
|
(22 |
) |
|
13.9 |
% |
Income tax provision, as adjusted (9) |
|
|
(140 |
) |
|
|
(103 |
) |
|
|
(37 |
) |
|
35.9 |
% |
Adjusted net income (Non-GAAP) |
|
$ |
400 |
|
|
$ |
292 |
|
|
$ |
108 |
|
|
37.0 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Diluted EPS (GAAP) |
|
$ |
0.64 |
|
|
$ |
0.28 |
|
|
$ |
0.36 |
|
|
128.6 |
% |
Restructuring and asset impairment costs(1) |
|
|
— |
|
|
|
0.04 |
|
|
|
(0.04 |
) |
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
0.14 |
|
|
|
0.14 |
|
|
|
— |
|
|
— |
% |
LIFO reserve change (3) |
|
|
0.57 |
|
|
|
0.60 |
|
|
|
(0.03 |
) |
|
(5.0 |
)% |
Loss on extinguishment of debt (4) |
|
|
— |
|
|
|
0.09 |
|
|
|
(0.09 |
) |
|
(100.0 |
)% |
Business transformation costs (5) |
|
|
0.16 |
|
|
|
0.07 |
|
|
|
0.09 |
|
|
128.6 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
(0.06 |
) |
|
|
0.06 |
|
|
(100.0 |
)% |
COVID-19 other related expenses (7) |
|
|
0.01 |
|
|
|
— |
|
|
|
0.01 |
|
|
NM |
|
Business acquisition and integration related costs and other (8) |
|
|
0.21 |
|
|
|
0.01 |
|
|
|
0.20 |
|
|
NM |
|
Income tax impact of adjustments (9) |
|
|
(0.14 |
) |
|
|
— |
|
|
|
(0.14 |
) |
|
NM |
|
Adjusted Diluted EPS (Non-GAAP) (10) |
|
$ |
1.59 |
|
|
$ |
1.17 |
|
|
$ |
0.42 |
|
|
35.9 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Weighted-average diluted shares outstanding (Non-GAAP) (11) |
|
|
251,057,880 |
|
|
|
249,692,471 |
|
|
|
|
|
|||
|
|
|
|
|
|
|
|
|
|||||||
Gross profit (GAAP) |
|
$ |
4,038 |
|
|
$ |
3,413 |
|
|
$ |
625 |
|
|
18.3 |
% |
LIFO reserve change (3) |
|
|
143 |
|
|
|
150 |
|
|
|
(7 |
) |
|
(4.7 |
)% |
Adjusted Gross profit (Non-GAAP) |
|
$ |
4,181 |
|
|
$ |
3,563 |
|
|
$ |
618 |
|
|
17.3 |
% |
|
|
|
|
|
|
|
|
|
|||||||
Operating expenses (GAAP) |
|
$ |
3,640 |
|
|
$ |
3,126 |
|
|
$ |
514 |
|
|
16.4 |
% |
Depreciation expense |
|
|
(240 |
) |
|
|
(242 |
) |
|
|
2 |
|
|
(0.8 |
)% |
Amortization expense |
|
|
(33 |
) |
|
|
(44 |
) |
|
|
11 |
|
|
(25.0 |
)% |
Restructuring and asset impairment costs(1) |
|
|
— |
|
|
|
(11 |
) |
|
|
11 |
|
|
(100.0 |
)% |
Share-based compensation expense (2) |
|
|
(34 |
) |
|
|
(36 |
) |
|
|
2 |
|
|
(5.6 |
)% |
Business transformation costs (5) |
|
|
(41 |
) |
|
|
(17 |
) |
|
|
(24 |
) |
|
141.2 |
% |
COVID-19 bad debt benefit (6) |
|
|
— |
|
|
|
15 |
|
|
|
(15 |
) |
|
(100.0 |
)% |
COVID-19 other related expenses (7) |
|
|
(2 |
) |
|
|
(1 |
) |
|
|
(1 |
) |
|
100.0 |
% |
Business acquisition and integration related costs and other (8) |
|
|
(53 |
) |
|
|
(3 |
) |
|
|
(50 |
) |
|
NM |
|
Adjusted Operating expenses (Non-GAAP) |
|
$ |
3,237 |
|
|
$ |
2,787 |
|
|
$ |
450 |
|
|
16.1 |
% |
NM - Not Meaningful | ||
(1) |
Consists primarily of non-CEO severance and related costs, organizational realignment costs and asset impairment charges. |
|
(2) |
Share-based compensation expense for expected vesting of stock awards and employee stock purchase plan. |
|
(3) |
Represents the impact of LIFO reserve adjustments. |
|
(4) |
Includes early redemption premium and the write-off of certain pre-existing debt issuance costs. |
|
(5) |
Consists primarily of costs related to significant process and systems redesign across multiple functions. |
|
(6) |
Includes the changes in the reserve for doubtful accounts expense reflecting the collection risk associated with our customer base as a result of the COVID-19 pandemic. |
|
(7) |
Includes COVID-19 related costs that we are permitted to addback for purposes of calculating Adjusted EBITDA under certain agreements governing our indebtedness. |
|
(8) |
Includes: (i) aggregate acquisition and integration related costs of |
|
(9) |
Represents our income tax provision adjusted for the tax effect of pre-tax items excluded from Adjusted net income and the removal of applicable discrete tax items. Applicable discrete tax items include changes in tax laws or rates, changes related to prior year unrecognized tax benefits, discrete changes in valuation allowances, and excess tax benefits associated with share-based compensation. The tax effect of pre-tax items excluded from Adjusted net income is computed using a statutory tax rate after taking into account the impact of permanent differences and valuation allowances. |
|
(10) |
Adjusted Diluted EPS is calculated as Adjusted net income divided by weighted average diluted shares outstanding (Non-GAAP). |
|
(11) |
For purposes of the Adjusted Diluted EPS calculation (Non-GAAP), when the Company has net income (GAAP), weighted average diluted shares outstanding (Non-GAAP) is used and assumes conversion of the Series A convertible preferred stock, and, when the Company has net loss (GAAP) and assumed conversion of the Series A convertible preferred stock would be antidilutive, weighted-average diluted shares outstanding (GAAP) is used. |
Non-GAAP Reconciliation Net Debt and Net Leverage Ratios |
||||||||||||
($ in millions, except ratios) |
|
|
|
|
|
|
||||||
Total Debt (GAAP) |
|
$ |
4,937 |
|
|
$ |
5,011 |
|
|
$ |
5,396 |
|
Cash, cash equivalents and restricted cash |
|
|
(366 |
) |
|
|
(148 |
) |
|
|
(772 |
) |
Net Debt (Non-GAAP) |
|
$ |
4,571 |
|
|
$ |
4,863 |
|
|
$ |
4,624 |
|
Adjusted EBITDA (1) |
|
$ |
1,222 |
|
|
$ |
1,057 |
|
|
$ |
969 |
|
Net Leverage Ratio (2) |
|
|
3.7 |
|
|
|
4.6 |
|
|
|
4.8 |
|
(1) |
Trailing Twelve Months (TTM) Adjusted EBITDA |
|
(2) |
Net Debt/TTM Adjusted EBITDA |
View source version on businesswire.com: https://www.businesswire.com/news/home/20221109006067/en/
INVESTOR CONTACT:
(847) 720-1688
Adam.Dabrowski@usfoods.com
MEDIA CONTACT:
(847) 720-2392
Sara.Matheu@usfoods.com
Source:
FAQ
What were the third quarter 2022 earnings for US Foods Holding Corp. (USFD)?
How much did USFD's adjusted EBITDA increase in Q3 2022?
What is the new share repurchase program amount for US Foods Holding Corp.?
What is the fiscal year 2022 guidance for US Foods Holding Corp.?